G. Biolcati

814 total citations
33 papers, 487 citations indexed

About

G. Biolcati is a scholar working on Molecular Biology, Rheumatology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, G. Biolcati has authored 33 papers receiving a total of 487 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 10 papers in Rheumatology and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in G. Biolcati's work include Porphyrin Metabolism and Disorders (21 papers), Heme Oxygenase-1 and Carbon Monoxide (11 papers) and Folate and B Vitamins Research (10 papers). G. Biolcati is often cited by papers focused on Porphyrin Metabolism and Disorders (21 papers), Heme Oxygenase-1 and Carbon Monoxide (11 papers) and Folate and B Vitamins Research (10 papers). G. Biolcati collaborates with scholars based in Italy, Switzerland and United Kingdom. G. Biolcati's co-authors include Elisabeth I. Minder, Luca Barbieri, Samantha Cialfi, Claudio Talora, Isabella Screpanti, Xiaoye Schneider‐Yin, X. Schneider‐Yin, Emanuela Marchesini, Jasmin Barman‐Aksözen and Maria Domenica Cappellini and has published in prestigious journals such as Scientific Reports, Journal of Investigative Dermatology and Biochimica et Biophysica Acta (BBA) - Molecular Cell Research.

In The Last Decade

G. Biolcati

33 papers receiving 474 citations

Peers

G. Biolcati
G. Biolcati
Citations per year, relative to G. Biolcati G. Biolcati (= 1×) peers Roxane Hervé

Countries citing papers authored by G. Biolcati

Since Specialization
Citations

This map shows the geographic impact of G. Biolcati's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. Biolcati with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. Biolcati more than expected).

Fields of papers citing papers by G. Biolcati

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G. Biolcati. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. Biolcati. The network helps show where G. Biolcati may publish in the future.

Co-authorship network of co-authors of G. Biolcati

This figure shows the co-authorship network connecting the top 25 collaborators of G. Biolcati. A scholar is included among the top collaborators of G. Biolcati based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G. Biolcati. G. Biolcati is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Biolcati, G., S. Hanneken, Elisabeth I. Minder, et al.. (2021). Validation of a novel patient reported tool to assess the impact of treatment in erythropoietic protoporphyria: the EPP-QoL. Journal of Patient-Reported Outcomes. 5(1). 65–65. 10 indexed citations
2.
Cialfi, Samantha, Loredana Le Pera, Rocco Palermo, et al.. (2016). The loss of ATP2C1 impairs the DNA damage response and induces altered skin homeostasis: Consequences for epidermal biology in Hailey-Hailey disease. Scientific Reports. 6(1). 31567–31567. 20 indexed citations
3.
Zanni, Elena, Samantha Cialfi, G. Biolcati, et al.. (2016). Glutathione S-transferase ϴ-subunit as a phenotypic suppressor of pmr1 Δ strain, the Kluyveromyces lactis model for Hailey-Hailey disease. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1863(11). 2650–2657. 8 indexed citations
4.
Biolcati, G., et al.. (2014). Long-term observational study of afamelanotide in 115 patients with erythropoietic protoporphyria. British Journal of Dermatology. 172(6). 1601–1612. 65 indexed citations
5.
Barman‐Aksözen, Jasmin, et al.. (2014). In ferrochelatase-deficient protoporphyria patients, ALAS2 expression is enhanced and erythrocytic protoporphyrin concentration correlates with iron availability. Blood Cells Molecules and Diseases. 54(1). 71–77. 33 indexed citations
6.
Manca, Sonia, Armando Magrelli, Samantha Cialfi, et al.. (2011). Oxidative stress activation of miR-125b is part of the molecular switch for Hailey-Hailey disease manifestation. Experimental Dermatology. 20(11). 932–937. 56 indexed citations
7.
D’Agosto, Giovanna, Elisabetta Trento, L. Nosotti, et al.. (2010). CD81 expression on CD19+ peripheral blood lymphocytes is associated with chronic HCV disease and increased risk for HCV infection: a putative role for inflammatory cytokines.. PubMed. 23(3). 155–64. 13 indexed citations
8.
Cialfi, Samantha, Simona Ceccarelli, Cinzia Marchese, et al.. (2009). Complex multipathways alterations and oxidative stress are associated with Hailey-Hailey disease. British Journal of Dermatology. 162(3). 518–526. 31 indexed citations
9.
Schneider‐Yin, Xiaoye, et al.. (2006). Heterogeneity of mutations in the ferrochelatase gene in Italian patients with erythropoietic protoporphyria. Molecular Genetics and Metabolism. 90(4). 402–407. 15 indexed citations
10.
Majore, Silvia, et al.. (2005). ATP2C1 Gene Mutation Analysis in Italian Patients with Hailey–Hailey Disease. Journal of Investigative Dermatology. 125(5). 933–935. 15 indexed citations
11.
Biolcati, G., et al.. (2004). Dermatological Marks in Athletes of Artistic and Rhythmic Gymnastics. International Journal of Sports Medicine. 25(8). 638–640. 4 indexed citations
12.
13.
Montemuros, Franco Martinez di, Elena Di Pierro, Dario Tavazzi, et al.. (2002). Molecular characterization of porphyrias in Italy: a diagnostic flow-chart.. PubMed. 48(8). 867–76. 7 indexed citations
14.
Grieco, Antonio, Paola Di Rocco, Luca Miele, et al.. (2001). Non-alcoholic steatohepatitis induced by carbamazepine and variegate porphyria. European Journal of Gastroenterology & Hepatology. 13(8). 973–975. 11 indexed citations
15.
Montemuros, Franco Martinez di, Elena Di Pierro, G. Biolcati, et al.. (2001). Acute Intermittent Porphyria: Heterogeneity of Mutations in the Hydroxymethylbilane Synthase Gene in Italy. Blood Cells Molecules and Diseases. 27(6). 961–970. 13 indexed citations
16.
Montemuros, Franco Martinez di, Elena Di Pierro, Silvia Fargion, et al.. (2000). Molecular analysis of the hydroxymethylbilane synthase (HMBS) gene in Italian patients with acute intermittent porphyria: Report of four novel mutations. Human Mutation. 15(5). 480–480. 10 indexed citations
17.
Biolcati, G., et al.. (1997). Creeping Eruption of Larva Migrans -A Case Report in a Beach Volley Athlete. International Journal of Sports Medicine. 18(8). 612–613. 17 indexed citations
18.
Biolcati, G., et al.. (1993). Frequency of viral hepatitis markers in porphyria cutanea tarda. European Journal of Dermatology. 3(3). 180–182. 7 indexed citations
19.
Biolcati, G., et al.. (1992). Incidence of hereditary porphyria cutanea tarda (PCT) in a sample of the Italian population. Archives of Dermatological Research. 284(4). 212–214. 4 indexed citations
20.
Biolcati, G., et al.. (1989). Does an association exist between PCT and SLE? Results of a study on autoantibodies in 158 patients affected with PCT. Archives of Dermatological Research. 281(4). 291–292. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026